Psychiatry · Olla, LA
NPI
1083636484
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1102 North Pine Street
Olla, LA, 71465
Phone (318) 495-3131
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$712K
9,942 prescriptions
Company payments, 2025
$39.68
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Phillip C Rowden prescribed most often to Medicare patients was Benztropine Mesylate, with 707 prescriptions and refills. In total Phillip C Rowden wrote 9,942 Medicare prescriptions that cost $712K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-08-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Benztropine Mesylate Generic | 707 | 709 | 66 | $11K |
| Divalproex Sodium Generic | 527 | 527 | 41 | $17K |
| Clonazepam Generic | 513 | 513 | 50 | $5,591 |
| Risperidone Generic | 418 | 418 | 34 | $6,511 |
| Clozapine Generic | 373 | 373 | 22 | $56K |
| Quetiapine Fumarate Generic | 360 | 360 | 30 | $8,394 |
| Paliperidone Er Paliperidone | 355 | 355 | 33 | $72K |
| Trazodone Hcl Generic | 338 | 342 | 32 | $5,949 |
| Lithium Carbonate Generic | 325 | 325 | 26 | $3,534 |
| Olanzapine Generic | 322 | 322 | 26 | $8,629 |
| Lamotrigine Generic | 287 | 287 | 20 | $5,112 |
| Haloperidol Generic | 272 | 272 | 25 | $15K |
| Divalproex Sodium Er Divalproex Sodium | 238 | 238 | 25 | $18K |
| Buspirone Hcl Generic | 205 | 205 | 20 | $4,232 |
| Oxcarbazepine Generic | 166 | 167 | 18 | $9,262 |
Brand drugs: 204 claims; generic drugs: 9,690 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Phillip C Rowden $39.68 ($39.68 in general payments such as food, travel and fees) from 2 companies. The largest payer was Collegium Pharmaceutical, Inc. with $20.36.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.